ResearcherAzienda Ospedaliera Citta' della Salute e della Scienza di TorinoActive in the last 2 years
Cecilia Roux
Matched on ORCID iD 0000-0002-2883-167X; OpenAlex author ID A5054420825. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 6
- The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinoma. Co-author DOI 10.1002/ctm2.70442↗
- PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer. Co-author DOI 10.1186/s13046-024-03080-1↗
- IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions. Co-author DOI 10.1073/pnas.2020395118↗
- The dark side of immunotherapy: pancreatic cancer. First author DOI 10.20517/cdr.2020.13↗
- Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners. Co-author DOI 10.3390/cancers10020051↗
- Endogenous glutamine decrease is associated with pancreatic cancer progression. Co-author DOI 10.18632/oncotarget.20545↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Paola Cappello · 6 shared papers, 2017–2025 · strength 0.78
- Paper The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenoc… DOI 10.1002/ctm2.70442↗
- Paper PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic … DOI 10.1186/s13046-024-03080-1↗
- Paper The dark side of immunotherapy: pancreatic cancer. DOI 10.20517/cdr.2020.13↗
- Francesco Novelli · 6 shared papers, 2017–2025 · strength 0.78
- Paper The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenoc… DOI 10.1002/ctm2.70442↗
- Paper PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic … DOI 10.1186/s13046-024-03080-1↗
- Paper The dark side of immunotherapy: pancreatic cancer. DOI 10.20517/cdr.2020.13↗
- Claudia Curcio · 5 shared papers, 2017–2025 · strength 0.65
- Paper The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenoc… DOI 10.1002/ctm2.70442↗
- Paper PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic … DOI 10.1186/s13046-024-03080-1↗
- Paper IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumori… DOI 10.1073/pnas.2020395118↗
- Gianluca Mucciolo · 4 shared papers, 2020–2025 · strength 0.62
- Paper The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenoc… DOI 10.1002/ctm2.70442↗
- Paper PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic … DOI 10.1186/s13046-024-03080-1↗
- Paper The dark side of immunotherapy: pancreatic cancer. DOI 10.20517/cdr.2020.13↗
- Silvia Brugiapaglia · 3 shared papers, 2020–2025 · strength 0.52
- Paper The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenoc… DOI 10.1002/ctm2.70442↗
- Paper PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic … DOI 10.1186/s13046-024-03080-1↗
- Paper The dark side of immunotherapy: pancreatic cancer. DOI 10.20517/cdr.2020.13↗
- Giorgia Tiberi · 1 shared paper, 2025 · strength 0.20
- Giulia Adriani · 1 shared paper, 2025 · strength 0.20
- Judith A. Varner · 1 shared paper, 2024 · strength 0.18
- Michela Capello · 1 shared paper, 2021 · strength 0.10
- Rita Teresa Lawlor · 1 shared paper, 2021 · strength 0.10
- Aldo Scarpa Scarpa · 1 shared paper, 2021 · strength 0.10
- Giorgia Mandili · 1 shared paper, 2018 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.